Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Miquel Serra-Burriel

Has grant

Assistant Professor

University of Zurich

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Recent Grants

Grant: Open

From single disease reductionist research to informed Machine Learning: a new research paradigm for multimorbidity

Open Date: 2023-08-01

Close Date: 2027-07-31

Grant: Open

Spinal manual therapy versus nerve root injection for lumbar radiculopathy: the SALuBRITY randomised clinical trial

Open Date: 2023-06-01

Close Date: 2027-05-31

Grant: Close

Screening for liver fibrosis - population-based study across European countries

Open Date: 2020-01-01

Close Date: 2024-12-31

Grant: Close

SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS

Open Date: 2017-01-01

Close Date: 2021-12-31

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (10)

Matthias Schwenkglenks

University of Zurich

SWITZERLAND

View details

Ferran Torres

Associate Professor. Head of Unit

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Maja Thiele

Odense University Hospital

DENMARK

View details

Jürg Hans Beer

Consiglio d'amministratione

Clinica Luganese Moncucco

SWITZERLAND

View details

Kerstin Noëlle Vokinger

University of Zurich

SWITZERLAND

View details

Susana Castan Cameo

Head of the Population Programs Service for the Early Detection of Health Problems

SPAIN

View details

Rafael Bañares

Full Professor

Universidad Complutense de Madrid

SPAIN

View details

Enrique Quintero

Professor

Universidad de La Laguna Facultad de Farmacia

SPAIN

View details

Joseph Ross

Professor

Yale University School of Medicine

UNITED STATES

View details

Pere Ginès

University of Barcelona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Miquel Serra-Burriel

Research Interests

Explore related searches

Recent Grants

Articles (20)

Prevalence of liver fibrosis in the general population (the LiverScreen project)

Machine Learning Methods for Estimating Personalized Treatment Effects—Insights on validity from two large trials

Quantification of Age and Sex Ratio Differences between Trial and Target Population for New Drugs

Liver Health: An Emerging Concept

Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.

Impact of atrial fibrillation on productivity in working-age patients: an analysis of Swiss-AF prospective cohort study data

Differences Between Trial Populations and Approved Label Populations of New Drugs in the United States and Europe (2012 to 2023)

Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trial.

ESMO-MCBS v2.0: Advances, challenges, and perspectives in the assessment of clinical benefit in oncology

Colonoscopy versus faecal immunochemical testing in COLONPREV – Authors' reply

Metabolic Dysfunction-Associated Steatotic Liver Disease-The New Epidemic of Chronic Liver Disease.

Drug Prices After Patent Expirations in High-Income Countries and Implications for Cost-Effectiveness Analyses

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus: Growing Evidence But Not Yet There

Why effect sizes are systematically larger for progression-free survival than overall survival in cancer drug trials: Prognostic scores as a way forward

Launch and Postlaunch Price Developments of New Drugs in the US, Germany, and Switzerland

Fusion versus decompression alone for lumbar degenerative spondylolisthesis and spinal stenosis: a target trial emulation with index trial benchmarking

Time From Approval to Reimbursement of New Drugs: A Comparative Analysis Between the United States, England, Germany, France, and Switzerland (2011–2022)

Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort

A discrete choice experiment on price and flavour effects on the appeal of nicotine products: a pilot study among young adults in Switzerland

Comparative Analysis of Drug Shortages in the US and Germany (2016 – 2023)

Collaborators (10)

Matthias Schwenkglenks

Ferran Torres

Maja Thiele

Jürg Hans Beer

Kerstin Noëlle Vokinger

Susana Castan Cameo

Rafael Bañares

Enrique Quintero

Joseph Ross

Pere Ginès

Make your next move.